-
Je něco špatně v tomto záznamu ?
The cost of inflammatory bowel disease in high-income settings: a Lancet Gastroenterology & Hepatology Commission
J. Burisch, M. Zhao, S. Odes, P. De Cruz, S. Vermeire, CN. Bernstein, GG. Kaplan, D. Duricova, D. Greenberg, HO. Melberg, M. Watanabe, HS. Ahn, L. Targownik, VEH. Pittet, V. Annese, KT. Park, KH. Katsanos, ML. Høivik, Z. Krznaric, M. Chaparro,...
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články, přehledy, práce podpořená grantem
- MeSH
- Crohnova nemoc * epidemiologie MeSH
- gastroenterologie * MeSH
- idiopatické střevní záněty * epidemiologie terapie MeSH
- lidé MeSH
- náklady na zdravotní péči MeSH
- ulcerózní kolitida * epidemiologie terapie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
The cost of caring for patients with inflammatory bowel disease (IBD) continues to increase worldwide. The cause is not only a steady increase in the prevalence of Crohn's disease and ulcerative colitis in both developed and newly industrialised countries, but also the chronic nature of the diseases, the need for long-term, often expensive treatments, the use of more intensive disease monitoring strategies, and the effect of the diseases on economic productivity. This Commission draws together a wide range of expertise to discuss the current costs of IBD care, the drivers of increasing costs, and how to deliver affordable care for IBD in the future. The key conclusions are that (1) increases in health-care costs must be evaluated against improved disease management and reductions in indirect costs, and (2) that overarching systems for data interoperability, registries, and big data approaches must be established for continuous assessment of effectiveness, costs, and the cost-effectiveness of care. International collaborations should be sought out to evaluate novel models of care (eg, value-based health care, including integrated health care, and participatory health-care models), as well as to improve the education and training of clinicians, patients, and policy makers.
Advanced Research Institute Tokyo Medical and Dental University Tokyo Japan
Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas Madrid Spain
Department of Community Medicine University of Tromsø The Arctic University of Norway Tromsø Norway
Department of Gastroenterology and Hepatology University Hospital Leuven Leuven Belgium
Department of Gastroenterology Austin Health Melbourne VIC Australia
Department of Gastroenterology Copenhagen University Hospital North Zealand Hillerød Denmark
Department of Gastroenterology Hepatology and Nutrition University Hospital Zagreb Zagreb Croatia
Department of Gastroenterology Oslo University Hospital Oslo Norway
Department of Internal Medicine and Oncology Semmelweis University Budapest Hungary
Department of Medicine and Community Health Sciences University of Calgary Calgary AB Canada
Department of Medicine Austin Academic Centre The University of Melbourne Melbourne VIC Australia
Department of Medicine University of Otago Christchurch New Zealand
Department of Pharmacology Faculty of Medicine Charles University Prague Czech Republic
Department of Preventive Medicine College of Medicine Korea University Seoul South Korea
Department of Surgery Amsterdam University Medical Centers Amsterdam Netherlands
Department of Surgical Oncological and Gastroenterological Sciences University of Padua Padua Italy
Division of Gastroenterology McGill University Montreal QC Canada
Faculty of Health Sciences Ben Gurion University of the Negev Beer Sheva Israel
Faculty of Health Sciences University of Adelaide Adelaide SA Australia
Faculty of Medicine KU Leuven University Leuven Belgium
Gastro Unit Medical Division Copenhagen University Hospital Amager and Hvidovre Hvidovre Denmark
Genentech South San Francisco CA USA
IBD Clinical and Research Centre for IBD ISCARE Prague Czech Republic
IBD Clinical and Research Centre University of Manitoba Winnipeg MB Canada
IBD Unit St Mark's Hospital Middlesex UK
Institute of Clinical Medicine University of Oslo Oslo Norway
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23011585
- 003
- CZ-PrNML
- 005
- 20230801133148.0
- 007
- ta
- 008
- 230718s2023 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/S2468-1253(23)00003-1 $2 doi
- 035 __
- $a (PubMed)36871566
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Burisch, Johan $u Gastro Unit, Medical Division, Copenhagen University Hospital-Amager and Hvidovre, Hvidovre, Denmark; Copenhagen Center for Inflammatory Bowel Disease in Children, Adolescents and Adults, Copenhagen University Hospital-Amager and Hvidovre, Hvidovre, Denmark. Electronic address: johan.burisch@regionh.dk
- 245 14
- $a The cost of inflammatory bowel disease in high-income settings: a Lancet Gastroenterology & Hepatology Commission / $c J. Burisch, M. Zhao, S. Odes, P. De Cruz, S. Vermeire, CN. Bernstein, GG. Kaplan, D. Duricova, D. Greenberg, HO. Melberg, M. Watanabe, HS. Ahn, L. Targownik, VEH. Pittet, V. Annese, KT. Park, KH. Katsanos, ML. Høivik, Z. Krznaric, M. Chaparro, EV. Loftus, PL. Lakatos, JP. Gisbert, W. Bemelman, B. Moum, RB. Gearry, MD. Kappelman, A. Hart, MJ. Pierik, JM. Andrews, SC. Ng, R. D'Inca, P. Munkholm
- 520 9_
- $a The cost of caring for patients with inflammatory bowel disease (IBD) continues to increase worldwide. The cause is not only a steady increase in the prevalence of Crohn's disease and ulcerative colitis in both developed and newly industrialised countries, but also the chronic nature of the diseases, the need for long-term, often expensive treatments, the use of more intensive disease monitoring strategies, and the effect of the diseases on economic productivity. This Commission draws together a wide range of expertise to discuss the current costs of IBD care, the drivers of increasing costs, and how to deliver affordable care for IBD in the future. The key conclusions are that (1) increases in health-care costs must be evaluated against improved disease management and reductions in indirect costs, and (2) that overarching systems for data interoperability, registries, and big data approaches must be established for continuous assessment of effectiveness, costs, and the cost-effectiveness of care. International collaborations should be sought out to evaluate novel models of care (eg, value-based health care, including integrated health care, and participatory health-care models), as well as to improve the education and training of clinicians, patients, and policy makers.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a gastroenterologie $7 D005762
- 650 12
- $a idiopatické střevní záněty $x epidemiologie $x terapie $7 D015212
- 650 12
- $a Crohnova nemoc $x epidemiologie $7 D003424
- 650 12
- $a ulcerózní kolitida $x epidemiologie $x terapie $7 D003093
- 650 _2
- $a náklady na zdravotní péči $7 D017048
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Zhao, Mirabella $u Gastro Unit, Medical Division, Copenhagen University Hospital-Amager and Hvidovre, Hvidovre, Denmark; Copenhagen Center for Inflammatory Bowel Disease in Children, Adolescents and Adults, Copenhagen University Hospital-Amager and Hvidovre, Hvidovre, Denmark
- 700 1_
- $a Odes, Selwyn $u Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel
- 700 1_
- $a De Cruz, Peter $u Department of Gastroenterology, Austin Health, Melbourne, VIC, Australia; Department of Medicine, Austin Academic Centre, The University of Melbourne, Melbourne, VIC, Australia
- 700 1_
- $a Vermeire, Severine $u Department of Gastroenterology and Hepatology, University Hospital Leuven, Leuven, Belgium; Faculty of Medicine, KU Leuven University, Leuven, Belgium
- 700 1_
- $a Bernstein, Charles N $u IBD Clinical and Research Centre, University of Manitoba, Winnipeg, MB, Canada; Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada
- 700 1_
- $a Kaplan, Gilaad G $u Department of Medicine and Community Health Sciences, University of Calgary, Calgary, AB, Canada
- 700 1_
- $a Duricova, Dana $u IBD Clinical and Research Centre for IBD, ISCARE, Prague, Czech Republic; Department of Pharmacology, Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Greenberg, Dan $u Department of Health Policy and Management, School of Public Health, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel; Guilford Glazer Faculty of Business and Management, Ben-Gurion University of the Negev, Beer-Sheva, Israel
- 700 1_
- $a Melberg, Hans O $u Department of Community Medicine, University of Tromsø-The Arctic University of Norway, Tromsø, Norway; Department of Gastroenterology, Oslo University Hospital, Oslo, Norway
- 700 1_
- $a Watanabe, Mamoru $u Advanced Research Institute, Tokyo Medical and Dental University, Tokyo, Japan
- 700 1_
- $a Ahn, Hyeong Sik $u Department of Preventive Medicine, College of Medicine, Korea University, Seoul, South Korea
- 700 1_
- $a Targownik, Laura $u Division of Gastroenterology and Hepatology, Department of Medicine, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada
- 700 1_
- $a Pittet, Valérie E H $u Department of Epidemiology and Health Systems, Center for Primary Care and Public Health, University of Lausanne, Lausanne, Switzerland
- 700 1_
- $a Annese, Vito $u Division of Gastroenterology, Department of Internal Medicine, Fakeeh University Hospital, Dubai, United Arab Emirates
- 700 1_
- $a Park, K T $u Stanford Health Care, Packard Health Alliance, Alameda, CA, USA; Genentech (Roche Group), South San Francisco, CA, USA
- 700 1_
- $a Katsanos, Konstantinos H $u Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, University of Ioannina School of Health Sciences, Ioannina, Greece
- 700 1_
- $a Høivik, Marte L $u Department of Gastroenterology, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway
- 700 1_
- $a Krznaric, Zeljko $u Department of Gastroenterology, Hepatology and Nutrition, University Hospital Zagreb, Zagreb, Croatia
- 700 1_
- $a Chaparro, María $u Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa, Universidad Autónoma de Madrid, Madrid, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Madrid, Spain
- 700 1_
- $a Loftus, Edward V $u Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine and Science, Rochester, MN, USA
- 700 1_
- $a Lakatos, Peter L $u Division of Gastroenterology, McGill University Montreal, QC, Canada; Department of Internal Medicine and Oncology, Semmelweis University, Budapest, Hungary
- 700 1_
- $a Gisbert, Javier P $u Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa, Universidad Autónoma de Madrid, Madrid, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Madrid, Spain
- 700 1_
- $a Bemelman, Willem $u Department of Surgery, Amsterdam University Medical Centers, Amsterdam, Netherlands
- 700 1_
- $a Moum, Bjorn $u Institute of Clinical Medicine, University of Oslo, Oslo, Norway
- 700 1_
- $a Gearry, Richard B $u Department of Medicine, University of Otago, Christchurch, New Zealand
- 700 1_
- $a Kappelman, Michael D $u Division of Pediatric Gastroenterology, Department of Pediatrics and Center for Gastrointestinal Biology and Disease, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
- 700 1_
- $a Hart, Ailsa $u IBD Unit, St Mark's Hospital, Middlesex, UK
- 700 1_
- $a Pierik, Marieke J $u Department of Internal Medicine, Division of Gastroenterology and Hepatology, Maastricht University Medical Centre, Maastricht, Netherlands
- 700 1_
- $a Andrews, Jane M $u IBD Service, Department of Gastroenterology and Hepatology, Royal Adelaide Hospital, Adelaide, SA, Australia; Faculty of Health Sciences, University of Adelaide, Adelaide, SA, Australia
- 700 1_
- $a Ng, Siew C $u Department of Medicine and Therapeutics, Li Ka Shing Institute of Health Sciences, State Key Laboratory of Digestive Disease, Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China
- 700 1_
- $a D'Inca, Renata $u Department of Surgical, Oncological and Gastroenterological Sciences, University of Padua, Padua, Italy
- 700 1_
- $a Munkholm, Pia $u Department of Gastroenterology, Copenhagen University Hospital-North Zealand, Hillerød, Denmark
- 773 0_
- $w MED00196700 $t The lancet. Gastroenterology & hepatology $x 2468-1253 $g Roč. 8, č. 5 (2023), s. 458-492
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36871566 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230718 $b ABA008
- 991 __
- $a 20230801133145 $b ABA008
- 999 __
- $a ok $b bmc $g 1963799 $s 1197850
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 8 $c 5 $d 458-492 $e 20230302 $i 2468-1253 $m The lancet. Gastroenterology & hepatology $n Lancet Gastroenterol Hepatol $x MED00196700
- LZP __
- $a Pubmed-20230718
